Nanologica AB (DE:4YD)
FRANKFURT:4YD
Germany Market
Holding DE:4YD?
Track your performance easily

Nanologica AB (4YD) Financial Statements

0 Followers

Nanologica AB Financial Overview

Nanologica AB's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Nanologica AB is scheduled to report earnings on October 25, 2024, and the estimated EPS forecast is €-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuekr 674.00Kkr 401.00Kkr 210.00Kkr 270.00Kkr 676.00K
Gross Profitkr 1.43Mkr 1.35Mkr 1.13Mkr -681.00Kkr -2.15M
EBITkr -13.40Mkr -9.48Mkr -12.20Mkr -15.12Mkr -14.44M
EBITDAkr -10.30Mkr -6.51Mkr -9.29Mkr -12.23Mkr -11.58M
Net Income Common Stockholderskr -14.86Mkr -10.99Mkr -13.47Mkr -15.91Mkr -15.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 70.32Mkr 9.69Mkr 30.71Mkr 5.13Mkr 11.70M
Total Assetskr 154.51Mkr 91.75Mkr 114.05Mkr 90.39Mkr 98.32M
Total Debtkr 4.69Mkr 22.89Mkr 17.08Mkr 8.44Mkr 9.79M
Net Debtkr -65.63Mkr 13.20Mkr -13.63Mkr 3.31Mkr -1.91M
Total Liabilitieskr 81.36Mkr 82.24Mkr 91.84Mkr 54.71Mkr 46.72M
Stockholders Equitykr 73.16Mkr 9.50Mkr 22.21Mkr 35.68Mkr 51.60M
Cash Flow-
Free Cash Flowkr -14.82Mkr -9.96Mkr -13.31Mkr -15.69Mkr -16.31M
Operating Cash Flowkr -11.72Mkr -6.75Mkr -12.01Mkr -14.74Mkr -15.21M
Investing Cash Flowkr -2.18Mkr -2.79Mkr -1.23Mkr -942.00Kkr -1.09M
Financing Cash Flowkr 75.60Mkr -11.19Mkr 38.64Mkr 8.65Mkr -1.33M
Currency in SEK

Nanologica AB Earnings and Revenue History

Nanologica AB Debt to Assets

Nanologica AB Cash Flow

Nanologica AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis